Heidelberg Pharma AG (HPHA) | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 10/24/2024 at 11:08, 10 days 2 hours ago

Heidelberg Pharma présentera ses innovations ADC en novembre 2024

Heidelberg Pharma HDP-101 Thérapie Contre Le Cancer ADC HDP-201
BRIEF

published on 10/24/2024 at 11:08, 10 days 2 hours ago

Heidelberg Pharma to Showcase Its ADC Innovations in November 2024

Cancer Therapy Heidelberg Pharma HDP-101 ADCs HDP-201
PRESS RELEASE

published on 10/24/2024 at 11:03, 10 days 2 hours ago

Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024
Heidelberg Pharma to present ADC candidates at scientific and financial conferences in November 2024. Updates on Amanitin-based HDP-101 and Exatecan-based HDP-201. Key targets and conference details

Heidelberg Pharma Scientific Conferences ADC Candidates Amanitin Exatecan
BRIEF

published on 10/10/2024 at 07:11, 24 days 5 hours ago

Rapport intermédiaire de Heidelberg Pharma AG pour les neuf premiers mois de 2024

Rapport Financier Heidelberg Pharma Résultats Cliniques Essai Du HDP-101 Vente De Redevances
BRIEF

published on 10/10/2024 at 07:11, 24 days 5 hours ago

Heidelberg Pharma AG's Interim Report for First Nine Months of 2024

Financial Report Heidelberg Pharma HDP-101 Trial Clinical Outcomes Royalty Sale
PRESS RELEASE

published on 10/10/2024 at 07:06, 24 days 6 hours ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
Heidelberg Pharma AG provides insights on its operational progress and financial figures for the first nine months of fiscal year 2024. Development activities, new clinical data, R&D webinars, and guidance updates are highlighted

Financial Figures Clinical Data Heidelberg Pharma AG R&D Webinars Guidance Updates
BRIEF

published on 10/01/2024 at 17:34, 1 month 1 day ago

Heidelberg Pharma présente des données cliniques prometteuses pour le candidat ADC phare HDP-101

Heidelberg Pharma HDP-101 Myélome Multiple ADC Données Cliniques
BRIEF

published on 10/01/2024 at 17:34, 1 month 1 day ago

Heidelberg Pharma Presents Promising Clinical Data for Lead ADC Candidate HDP-101

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC
PRESS RELEASE

published on 10/01/2024 at 17:29, 1 month 1 day ago

Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
Heidelberg Pharma presents new clinical data on lead ADC candidate HDP-101 at IMS 2024, showing complete remission in one patient. Company developing innovative ADCs for cancer treatment

Clinical Data Heidelberg Pharma ADC IMS 2024 Complete Remission
BRIEF

published on 10/01/2024 at 15:32, 1 month 1 day ago

Heidelberg Pharma AG Announces Updated Financial Guidance

Financial Year 2024 Heidelberg Pharma Operating Expenses Updated Guidance Cash Requirements

1 2 ... 7

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 23 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 17 hours 53 minutes ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 20 hours 58 minutes ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 38 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 19 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE